-
Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.
Williams-Gray CH, Goris A, Foltynie T, Brown J, Maranian M, Walton A, Compston DA, Sawcer SJ, Barker RA.
J Neurol Neurosurg Psychiatry. 2006 May; 77(5):665-7.
[J Neurol Neurosurg Psychiatry. 2006]
-
Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.
Paisán-Ruíz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellström O, Duckworth J, Papadimitriou A, et al.
J Med Genet. 2006 Feb; 43(2):e9.
[J Med Genet. 2006]
-
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, Ross CA.
Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18676-81. Epub 2005 Dec 13.
[Proc Natl Acad Sci U S A. 2005]